Coherus All But Checks Out Of Biosimilars With Meitheal Adalimumab Deal

Yusimry Biosimilar Divested To Hong Kong King-Friend For $40m Upfront

 
• By Dean Rudge
Investing in new business while divesting in old industry with an old tree shaped as a finance pie chart graph funding a green tree
• Source: Shutterstock

More from Deals

More from Business